Impact Factor
2.74
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.38
335 total citations
h5-index
22
h5 depth signal
Cited share
46.8%
118 of 252
Total citations
335
Citation footprint
Metric signal
1.19
External metric anchor
Self-citation
2.4%
8 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
537
Japan
137
China
121
India
103
Mexico
97
Citing Fields of Research
Musculoskeletal Disorders
887
Auto-Inflammatory Disorders
825
Hematology
117
Immunology
109
Dermatology
106
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
4,982
Articles tracked across the journal lifetime
Indexed publication set
252
118 cited publications
Last 12 months
120
10.0 publications/month
Open access share
3.3%
4 OA publications in the last year
Leading citing country
United States
537 citing publications
Leading citing field
Musculoskeletal Disorders
887 citing publications
Latest tracked publication
19 October 2026
10 recent records available
Coverage & Indexing History
v11n1, Feb. 2005-
v11n1, Feb. 2005-
Research Focus & Classification
Indexed Subjects
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
Contributor
Pan American League against Rheumatism
Broad Categories
Orthopedics
Physiology
Rheumatology
Musculoskeletal Disorders
Auto-Inflammatory Disorders
MeSH Descriptors
Musculoskeletal Diseases
Rheumatic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/rhu.0000000000002409
Open DOI
Real-world Evidence of Anifrolumab Use in Mexican Patients With Systemic Lupus Erythematosus: A Multicenter Observational Study
Background: Anifrolumab is a monoclonal antibody directed against type I interferon receptor subunit 1 (IFNAR1) that blocks the interferon signaling pathway associated with key inflammatory processes involved in the pathogenesis of syste...
02
DOI 10.1097/rhu.0000000000002410
Open DOI
The Relationship Between Pan Immune-Inflammation Value and Disease Activity in Ankylosing Spondylitis
Objectives: Ankylosing spondylitis (AS) is a chronic inflammatory disease affecting the axial skeleton and peripheral joints, causing pain, stiffness, and reduced function. Monitoring disease activity is crucial, but no specific laborato...
03
DOI 10.1097/rhu.0000000000002411
Open DOI
Performance of Large Language Models in Answering Juvenile Systemic Lupus Erythematosus Questions: A Blinded Expert-based Comparative Study
Background: Large language models are increasingly used to obtain medical information, but their performance in juvenile systemic lupus erythematosus remains insufficiently characterized. Objective: To compare expert-rated response quali...
04
DOI 10.1097/rhu.0000000000002406
Open DOI
Reduced Lumbar Lordosis in Fibromyalgia: Radiographic Evidence of Lumbar Straightening by L1-L5 Cobb Angle
Background: Reduced lumbar lordosis has been observed in patients with low back pain, but lumbar straightening has not been well characterized in fibromyalgia. We hypothesized that fibromyalgia would be associated with reduced lumbar cur...
05
DOI 10.1097/rhu.0000000000002408
Open DOI
Cycling Versus Swapping After First-Line TNF Inhibitor Failure in Psoriatic Arthritis: Real-World Insights From the Argentine RECCAPSO Registry
Objectives: Cycling within the same mechanism of action (MoA) or swapping to a different MoA are 2 strategies after failure of advanced therapy in psoriatic arthritis (PsA). We described the frequency, clinical characteristics, and treat...
06
DOI 10.1097/rhu.0000000000002407
Open DOI
Response By Manadan et al to Letter Regarding Article “In-Hospital Mortality After Coronary Artery Bypass Graft Surgery With and Without Systemic Lupus Erythematosus”
Was not provided for this article.
07
DOI 10.1097/rhu.0000000000002404
Open DOI
Concomitant Fibromyalgia in Patients With Other Rheumatic Diseases: Pain Level and Treatment Response
Introduction: Fibromyalgia commonly coexists with rheumatic diseases and may complicate disease assessment and management. This study evaluated whether patients with rheumatic diseases and concomitant fibromyalgia differed in pain severi...
08
DOI 10.1097/rhu.0000000000002405
Open DOI
Adjusting for a Comorbidity Index That Contains the Exposure: Systemic Lupus Erythematosus and Mortality After Coronary Artery Bypass Grafting
Was not provided for this article.
09
DOI 10.1097/rhu.0000000000002401
Open DOI
Knowledge, Attitudes, and Intention Toward HPV Vaccination Among Reproductive-aged Women With Rheumatic Diseases
Background/Objective: This single-center, observational, and pre-post interventional study design evaluated HPV vaccination knowledge, attitudes, and intentions among reproductive-aged women with autoimmune rheumatic diseases (ARDs). Met...
10
DOI 10.1097/rhu.0000000000002388
Open DOI
Recommendations of the Argentine Society of Rheumatology for the Treatment of Patients With Rheumatoid Arthritis. Update 2025 Part II. Definitions in the Context of RA Treatment and Therapeutic Strategies for Special Situations and Comorbidities
Background: In the context of treatment recommendations for rheumatoid arthritis (RA), it is important to establish definitions related to treatment adjusted in specific situations and in the presence of comorbidities. Objectives: To dev...
Bibliographical & Catalog Notes
At head of title, <Aug. 2002->: JCR.
Title from cover.
Place of publication varies.
Also issued online.
Vols. for <Aug. 2002-> are the official publication of PANLAR.
v. 12, no. 2 (Apr. 2006)20051228 Notice published Printed on acid-free paper